← Back to Search

Technology-Enhanced Family Navigation for Autism (ATTAIN NAV Trial)

N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up distributed at study completion, an average of 1 year.
Awards & highlights

ATTAIN NAV Trial Summary

This trial is testing a new way to help parents of children with autism get them the mental health care they need.

Who is the study for?
This trial is for children aged 4-16 with autism, who speak English or Spanish and are getting care at a participating practice. Caregivers of these children can also participate. Healthcare providers must work at the practice and have experience with autistic kids. For part of the study, kids need an official autism diagnosis and show significant symptoms on a checklist.Check my eligibility
What is being tested?
The ATTAIN NAV model is being tested to see if it helps families get mental health services faster for their autistic children in primary care settings. It's about adapting family navigation using technology to improve access to care.See study design
What are the potential side effects?
Since this intervention involves technology-enhanced services rather than medication, there aren't typical medical side effects; however, participants may experience increased stress or frustration if they encounter difficulties navigating the system.

ATTAIN NAV Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~distributed at study completion, an average of 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and distributed at study completion, an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of Intervention Measure (AIM)
Appropriateness of Intervention Measure (AIM)
Eyberg Child Behavior Inventory (ECBI)
+5 more

ATTAIN NAV Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Stage 3 EnrollmentExperimental Treatment1 Intervention
Addition of 2 clinics with modifications over 4 months including 5 PCPs per clinic (4 total clinics).
Group II: Stage 2 EnrollmentExperimental Treatment1 Intervention
Addition of 2 clinics with modifications over 4 months including 5 PCPs per clinic (4 total clinics).
Group III: Stage 1 EnrollmentExperimental Treatment1 Intervention
Enrollment of 2 clinics over 4 months including 5 PCPs per clinic (2 total clinics).
Group IV: 1 Month Baseline PeriodActive Control1 Intervention
Initial baseline period for rollout at 6 different clinics throughout the year-long intervention period using a step-wedge design.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,126 Previous Clinical Trials
1,552,801 Total Patients Enrolled
8 Trials studying Autism Spectrum Disorder
14,083 Patients Enrolled for Autism Spectrum Disorder
Kaiser PermanenteOTHER
539 Previous Clinical Trials
23,905,065 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
361 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,789 Previous Clinical Trials
2,690,240 Total Patients Enrolled
81 Trials studying Autism Spectrum Disorder
40,162 Patients Enrolled for Autism Spectrum Disorder

Media Library

ATTAIN NAV Technology-Enhanced Family Navigation Model Clinical Trial Eligibility Overview. Trial Name: NCT05344378 — N/A
ATTAIN NAV Technology-Enhanced Family Navigation Model 2023 Treatment Timeline for Medical Study. Trial Name: NCT05344378 — N/A
Autism Spectrum Disorder Research Study Groups: 1 Month Baseline Period, Stage 1 Enrollment, Stage 2 Enrollment, Stage 3 Enrollment
Autism Spectrum Disorder Clinical Trial 2023: ATTAIN NAV Technology-Enhanced Family Navigation Model Highlights & Side Effects. Trial Name: NCT05344378 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the eligibility criteria for participation in this trial?

"This medical trial seeks 190 individuals who have been diagnosed with autism spectrum disorder, ranging in age from 4 to 16 years old. In order to be eligible for participation, they must satisfy a range of criteria: these include being employed at a primary care practice that provides services to children on the autistic spectrum, having an ASD diagnosis documented in their medical chart, screening as clinically significant on the Pediatric Symptom Checklist and speaking either English or Spanish (for Aim 3 only). Caregivers linked to those taking part in Aim 3 also need to fulfil certain requirements."

Answered by AI

Are any persons over 45 years of age eligible for participation in this experiment?

"Children aged 4 to 16 can have the opportunity to enrol in this clinical trial. There are 252 studies for minors and 87 research programs accessible by seniors over 65 years of age."

Answered by AI

Is this trial still open for enrolling participants?

"Clinicaltrials.gov confirms that, as of October 31st 2022, this clinical trial is no longer recruiting. Initially posted on May 1st 2022, 333 other trials are still actively searching for patients to participate in their programs at present."

Answered by AI
Recent research and studies
~63 spots leftby May 2025